Holen Sie sich die Stockscreener-App
714.88
0.95%
-6.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$721.75
Offen:
$720
24-Stunden-Volumen:
822.06K
Relative Volume:
0.81
Marktkapitalisierung:
$89.44B
Einnahmen:
$359.05B
Nettoeinkommen (Verlust:
$3.30B
KGV:
27.68
EPS:
25.83
Netto-Cashflow:
$5.23B
1W Leistung:
-0.76%
1M Leistung:
+0.91%
6M Leistung:
+15.69%
1J Leistung:
+24.73%
1-Tages-Spanne:
$706.03
$726.58
1-Wochen-Bereich:
$704.99
$726.58
52-Wochen-Spanne:
$464.42
$731.00
Mckesson Corporation Stock (MCK) Company Profile
Firmenname
Mckesson Corporation
Sektor
Branche
Telefon
972-446-4800
Adresse
6555 STATE HIGHWAY 161, IRVING, TX
Vergleichen Sie MCK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
714.88 | 90.05B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
291.55 | 56.87B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
155.48 | 36.92B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
70.57 | 9.21B | 12.50B | 314.00M | 421.00M | 2.44 |
|
YI
111 Inc Adr
|
8.08 | 69.56M | 2.05B | -45.99M | 5.54M | -0.5634 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Fortgesetzt | Mizuho | Neutral |
| 2024-11-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Bestätigt | Leerink Partners | Outperform |
| 2024-08-08 | Bestätigt | Mizuho | Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-07-06 | Herabstufung | Argus | Buy → Hold |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Bestätigt | Barclays | Overweight |
| 2021-11-02 | Bestätigt | BofA Securities | Buy |
| 2021-11-02 | Bestätigt | Evercore ISI | Outperform |
| 2021-11-02 | Bestätigt | Jefferies | Buy |
| 2021-03-30 | Hochstufung | Argus | Hold → Buy |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-18 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-07-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-02 | Bestätigt | Mizuho | Neutral |
| 2018-01-24 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Mckesson Corporation Aktie (MCK) Neueste Nachrichten
McKesson Corporation (MCK) Finalizes Purchase of Core Ventures - Insider Monkey
McKesson Acquires 70% Stake In Core Ventures To Boost Community Oncology Access - Nasdaq
McKesson completes control acquisition of cancer care clinics for $2.5B - The Business Journals
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
McKesson Finalizes Acquisition of 70% Stake in Core Ventures for $2.49 Billion - marketscreener.com
McKesson to spin off Medical-Surgical Solutions segment, focus on high-growth oncology and biopharma markets - HME News
McKesson Acquires Core Ventures - citybiz
Is McKesson (MCK) Outperforming Other Medical Stocks This Year? - Yahoo Finance
McKesson (MCK): Wells Fargo Raises Price Target to $766 | MCK Stock News - GuruFocus
McKesson acquires majority stake in Core Ventures - Investing.com
McKesson Corporation Completes Acquisition of Core Ventures | MCK Stock News - GuruFocus
McKesson (MCK) Price Target Raised by Wells Fargo Analyst | MCK Stock News - GuruFocus
Argus Adjusts Price Target on McKesson to $775 From $660 - marketscreener.com
McKesson Corporation Completes Acquisition of Core Ventures - Business Wire
DFW remains well-represented on Fortune 500 - The Business Journals
Wells Fargo Adjusts Price Target on McKesson to $766 From $691, Maintains Equalweight Rating - marketscreener.com
Insider Sell Alert: Thomas Rodgers Sells Shares of McKesson Corp (MCK) - GuruFocus
In brief: Best Buy restructures, McKesson spins off, BOC responds, women reign - HME News
McKesson to Spin Off Medical-Surgical Company - MSN
McKesson Issues $2 Billion Notes for Acquisition - MSN
Insider Sell: Leann Smith Sells Shares of McKesson Corp (MCK) - GuruFocus
Insider Sell: Thomas Rodgers Sells Shares of McKesson Corp (MCK) - GuruFocus
McKesson CFO Vitalone sells $1.35 million in common stock By Investing.com - Investing.com South Africa
McKesson EVP LeAnn B. Smith sells $244,807 in stock By Investing.com - Investing.com Nigeria
McKesson CFO Vitalone sells $1.35 million in common stock - Investing.com Australia
McKesson’s EVP Thomas Rodgers sells $366,134 in stock By Investing.com - Investing.com India
McKesson’s EVP Thomas Rodgers sells $366,134 in stock - Investing.com
McKesson corp executive sells $68,201 in stock - Investing.com Australia
McKesson EVP LeAnn B. Smith sells $244,807 in stock - Investing.com
Ex-Dividend Reminder: Clearway Energy, NextEra Energy and McKesson - Nasdaq
Why McKesson (MCK) is a Top Value Stock for the Long-Term - Yahoo Finance
Nephron Research Adjusts McKesson Price Target to $780 From $750 - marketscreener.com
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock - sharewise
Here's Why McKesson (MCK) is a Strong Momentum Stock - Yahoo Finance
Here's How Much You Would Have Made Owning McKesson Stock In The Last 15 Years - Benzinga
McKesson’s chief HR officer LeAnn Smith sells shares worth $895,190 By Investing.com - Investing.com Nigeria
McKesson’s chief HR officer LeAnn Smith sells shares worth $895,190 - Investing.com India
McKesson Stock: Is Wall Street Bullish or Bearish? - MSN
McKesson Stock: Is Wall Street Bullish Or Bearish? - Barchart.com
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
McKesson’s SVP Rutledge Napoleon sells $394,494 in stock - Investing.com
McKesson’s SVP Rutledge Napoleon sells $394,494 in stock By Investing.com - Investing.com India
McKesson stock soars to all-time high of $728.49 amid robust growth - Investing.com Nigeria
McKesson Corp Files For Three-Part Notes Offering Size Not DisclosedSEC Filing - marketscreener.com
Jim Cramer Notes McKesson (MCK) Reported “Very Strong Set of Numbers” - Insider Monkey
McKesson: Sustained Rally Backed By Strong Financials - Seeking Alpha
Why McKesson Stock Bumped Modestly Higher Today - MSN
McKesson Full Year 2025 Earnings: EPS Beats Expectations - simplywall.st
McKesson To Spin-Off Its Medical-Surgical Solutions Business - Forbes
Finanzdaten der Mckesson Corporation-Aktie (MCK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):